EXORPHIA

Otemachi, Japan

EXORPHIA is a biotech startup that develops novel medicine using extracellular vesicles.

Aug 2025

Corporate Round

Top Investors

Keio Innovation InitiativeD3Rohto Pharmaceutical

19,000+ verified contacts

Emails, phones & LinkedIn profiles

Who are EXORPHIA's investors?

EXORPHIA's investors include Keio Innovation Initiative, D3, Rohto Pharmaceutical.

Where is EXORPHIA headquartered?

EXORPHIA is headquartered in Otemachi, Japan.

What does EXORPHIA do?

EXORPHIA is a biotech startup that develops novel medicine using extracellular vesicles.

What stage is EXORPHIA at?

EXORPHIA is at the Corporate Round stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated August 20, 2025.

MLA

"EXORPHIA — Funding & Investors." VCBacked, August 20, 2025, https://www.vcbacked.co/company/exorphia. Accessed July 1, 2026.

APA

VCBacked. (2025). EXORPHIA — Funding & Investors. Retrieved July 1, 2026, from https://www.vcbacked.co/company/exorphia

Wikipedia (cite web)

{{cite web |title=EXORPHIA — Funding & Investors |url=https://www.vcbacked.co/company/exorphia |website=VCBacked |access-date=July 1, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated August 20, 2025.